DRUG LIFE-CYCLE INSIGHTS ACROSS THE GLOBE

Pharmaceuticals  |  Biotech  |  Biosimilars

IPD's Life-Cycle Insights subscription serves as the foundation of our unmatched visibility into the life cycle of drugs and biologics, from early-stage pipeline assets to mature, established products. 

  • Brand, generic, and biosimilar launches

  • Loss-of-exclusivity insight and timing

  • Innovative product pipeline tracking

  • Litigation analysis and forecasted outcomes

  • Regulatory impacts

Our team of former patent litigators, former Federal Circuit Clerks, PhD scientists, and patent researchers analyze public and proprietary data to provide summarized, comprehensive, strategic, and tactical analysis and insights. 

   Our Life-Cycle Insights cover:

United States  |  Europe  | Japan  |  Brazil   |   Australia/New Zealand  Canada  |  Mexico  |  China  |  Russia   

Our subscribers gain around-the-clock access to IPD's proprietary web-based platform with real-time email alerts and expert consultations.

  • Data and analysis covering thousands of drugs and biologics in all major disease states and indications

  • Brand, generic, and biosimilar launch tracking tools to monitor new market entrants to the market and their impact on product pricing

  • Loss-of-exclusivity forecasts, patent information, regulatory data, generic-filer information, API information, disease-area overviews, competitive intelligence, and drug pipelines up to 10 years in the future

  • Information on pending litigation and regulatory proceedings such as court cases, hearings, and oppositions that affect launch timing, direct vs. indirect competitors, and marketplace shifts

Asset 211.png
2020 EOY Regional Award Winner Logo-01.p
LINKS
CONTACT & CONNECT

Headquarters:

19950 W Country Club Drive
7th Floor

Aventura, FL 33180

Australia

Brazil

Germany

India

Japan

Mexico

Netherlands

South Korea

Taiwan

info@ipdanalytics.com

+1 (305) 662-8515

  • LinkedIn Social Icon
  • Twitter Social Icon

© 2020 by IPD Analytics | Privacy Policy